Synovics Pharmaceuticals Price To Sales vs. Net Income
| SYVC Stock | USD 0.0001 0.00 0.000003% |
Synovics Pharmaceuticals Price To Sales Ratio |
|
For Synovics Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Synovics Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Synovics Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Synovics Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Synovics Pharmaceuticals over time as well as its relative position and ranking within its peers.
Check out World Market Map. Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synovics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synovics Pharmaceuticals is measured differently than its book value, which is the value of Synovics that is recorded on the company's balance sheet. Investors also form their own opinion of Synovics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Synovics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synovics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Synovics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synovics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Synovics Pharmaceuticals Net Income vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Synovics Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Synovics Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Synovics Pharmaceuticals is rated fourth in price to sales category among its peers. It is rated below average in net income category among its peers . At present, Synovics Pharmaceuticals' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Synovics Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Synovics Net Income vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Synovics Pharmaceuticals |
| = | 0.03 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Synovics Pharmaceuticals |
| = | (4.01 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Synovics Net Income Comparison
Synovics Pharmaceuticals is currently under evaluation in net income category among its peers.
Synovics Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Synovics Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Synovics Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Synovics Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Synovics Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -2.2 M | -2.3 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Income Before Tax | -3.6 M | -3.8 M | |
| Total Other Income Expense Net | -1.4 M | -1.4 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Change To Netincome | 5.2 M | 4.7 M | |
| Net Loss | (0.15) | (0.16) | |
| Income Quality | (1.11) | (1.05) | |
| Net Income Per E B T | 1.02 | 0.89 |
Synovics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Synovics Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Synovics Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Synovics Pharmaceuticals' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Synovics Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Use Investing Themes to Complement your Synovics Pharmaceuticals position
In addition to having Synovics Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Apparel Thematic Idea Now
Apparel
Companies manufacturing textile accessories and apparel products. The Apparel theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For information on how to trade Synovics Stock refer to our How to Trade Synovics Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
To fully project Synovics Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Synovics Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Synovics Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.